These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 28247754)
1. Small-Sized mPEG-PLGA Nanoparticles of Schisantherin A with Sustained Release for Enhanced Brain Uptake and Anti-Parkinsonian Activity. Chen T; Li C; Li Y; Yi X; Wang R; Lee SM; Zheng Y ACS Appl Mater Interfaces; 2017 Mar; 9(11):9516-9527. PubMed ID: 28247754 [TBL] [Abstract][Full Text] [Related]
2. Oral Delivery of a Nanocrystal Formulation of Schisantherin A with Improved Bioavailability and Brain Delivery for the Treatment of Parkinson's Disease. Chen T; Li C; Li Y; Yi X; Lee SM; Zheng Y Mol Pharm; 2016 Nov; 13(11):3864-3875. PubMed ID: 27740776 [TBL] [Abstract][Full Text] [Related]
3. Mithramycin-loaded mPEG-PLGA nanoparticles exert potent antitumor efficacy against pancreatic carcinoma. Liu XJ; Li L; Liu XJ; Li Y; Zhao CY; Wang RQ; Zhen YS Int J Nanomedicine; 2017; 12():5255-5269. PubMed ID: 28769562 [TBL] [Abstract][Full Text] [Related]
4. Preparation, in vitro and in vivo evaluation of mPEG-PLGA nanoparticles co-loaded with syringopicroside and hydroxytyrosol. Guan Q; Sun S; Li X; Lv S; Xu T; Sun J; Feng W; Zhang L; Li Y J Mater Sci Mater Med; 2016 Feb; 27(2):24. PubMed ID: 26704541 [TBL] [Abstract][Full Text] [Related]
5. A mPEG-PLGA-b-PLL copolymer carrier for adriamycin and siRNA delivery. Liu P; Yu H; Sun Y; Zhu M; Duan Y Biomaterials; 2012 Jun; 33(17):4403-12. PubMed ID: 22436800 [TBL] [Abstract][Full Text] [Related]
6. Development and evaluation of long-circulating nanoparticles loaded with betulinic acid for improved anti-tumor efficacy. Saneja A; Kumar R; Singh A; Dhar Dubey R; Mintoo MJ; Singh G; Mondhe DM; Panda AK; Gupta PN Int J Pharm; 2017 Oct; 531(1):153-166. PubMed ID: 28823888 [TBL] [Abstract][Full Text] [Related]
7. Poly(lactide-co-glycolide)-methoxy-poly(ethylene glycol) nanoparticles: drug loading and release properties. Katsikogianni G; Avgoustakis K J Nanosci Nanotechnol; 2006; 6(9-10):3080-6. PubMed ID: 17048521 [TBL] [Abstract][Full Text] [Related]
8. [Transport of mPEG-PLGA nanoparticles across the rat nasal mucosa]. Wang JT; Lin DH; Qin LF; Wen Z; Guo GP Yao Xue Xue Bao; 2013 May; 48(5):752-8. PubMed ID: 23888701 [TBL] [Abstract][Full Text] [Related]
9. Poly(vinyl methyl ether/maleic anhydride)-Doped PEG-PLA Nanoparticles for Oral Paclitaxel Delivery To Improve Bioadhesive Efficiency. Wang Q; Li C; Ren T; Chen S; Ye X; Guo H; He H; Zhang Y; Yin T; Liang XJ; Tang X Mol Pharm; 2017 Oct; 14(10):3598-3608. PubMed ID: 28892400 [TBL] [Abstract][Full Text] [Related]
10. PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms. Xie X; Tao Q; Zou Y; Zhang F; Guo M; Wang Y; Wang H; Zhou Q; Yu S J Agric Food Chem; 2011 Sep; 59(17):9280-9. PubMed ID: 21797282 [TBL] [Abstract][Full Text] [Related]
11. Pluronic P85/F68 Micelles of Baicalein Could Interfere with Mitochondria to Overcome MRP2-Mediated Efflux and Offer Improved Anti-Parkinsonian Activity. Chen T; Li Y; Li C; Yi X; Wang R; Lee SM; Zheng Y Mol Pharm; 2017 Oct; 14(10):3331-3342. PubMed ID: 28806519 [TBL] [Abstract][Full Text] [Related]
12. Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson's disease treatment. Bi C; Wang A; Chu Y; Liu S; Mu H; Liu W; Wu Z; Sun K; Li Y Int J Nanomedicine; 2016; 11():6547-6559. PubMed ID: 27994458 [TBL] [Abstract][Full Text] [Related]
13. Nanoparticles Mediating the Sustained Puerarin Release Facilitate Improved Brain Delivery to Treat Parkinson's Disease. Chen T; Liu W; Xiong S; Li D; Fang S; Wu Z; Wang Q; Chen X ACS Appl Mater Interfaces; 2019 Dec; 11(48):45276-45289. PubMed ID: 31638771 [TBL] [Abstract][Full Text] [Related]
14. In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells. Gao C; Pan J; Lu W; Zhang M; Zhou L; Tian J Anticancer Drugs; 2009 Oct; 20(9):807-14. PubMed ID: 19696655 [TBL] [Abstract][Full Text] [Related]
15. Polymeric Nanoparticles-Based Brain Delivery with Improved Therapeutic Efficacy of Ginkgolide B in Parkinson's Disease. Zhao Y; Xiong S; Liu P; Liu W; Wang Q; Liu Y; Tan H; Chen X; Shi X; Wang Q; Chen T Int J Nanomedicine; 2020; 15():10453-10467. PubMed ID: 33380795 [TBL] [Abstract][Full Text] [Related]
16. Idarubicin-loaded methoxy poly(ethylene glycol)- Liang B; Li N; Zhang S; Qi A; Feng J; Jing W; Shi C; Ma Z; Gao S Int J Nanomedicine; 2019; 14():543-556. PubMed ID: 30666113 [TBL] [Abstract][Full Text] [Related]
17. Novel PLGA-based nanoparticles for the oral delivery of insulin. Malathi S; Nandhakumar P; Pandiyan V; Webster TJ; Balasubramanian S Int J Nanomedicine; 2015; 10():2207-18. PubMed ID: 25848248 [TBL] [Abstract][Full Text] [Related]
18. Progesterone PLGA/mPEG-PLGA Hybrid Nanoparticle Sustained-Release System by Intramuscular Injection. Xie B; Liu Y; Guo Y; Zhang E; Pu C; He H; Yin T; Tang X Pharm Res; 2018 Feb; 35(3):62. PubMed ID: 29445971 [TBL] [Abstract][Full Text] [Related]
19. Oral delivery of indinavir using mPEG-PCL nanoparticles: preparation, optimization, cellular uptake, transport and pharmacokinetic evaluation. Kurd M; Sadegh Malvajerd S; Rezaee S; Hamidi M; Derakhshandeh K Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2123-2133. PubMed ID: 31155961 [No Abstract] [Full Text] [Related]
20. Biodegradable nanoparticles of mPEG-PLGA-PLL triblock copolymers as novel non-viral vectors for improving siRNA delivery and gene silencing. Du J; Sun Y; Shi QS; Liu PF; Zhu MJ; Wang CH; Du LF; Duan YR Int J Mol Sci; 2012; 13(1):516-533. PubMed ID: 22312268 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]